Letrozole efficacy is related to human aromatase CYP19 single nucleotide polymorphisms (SNPs) in metastatic breast cancer

Colomer, R; Monzo, M; Tusquets, I; Rifa, J; Baena, JM; Barnadas, A; Calvo, L; Carabantes, F; Crespo, C; Munoz, M; Llombart, A; Plazaola, A; Alba, E; Fuster, D; Gilabert, M; Lloveras, B

doi:10.1186/bcr1233

Identifier to cite or link to this item: http://hdl.handle.net/20.500.13003/14345

View

000232328800030.pdf (518.2Kb)

Identifiers

URI: http://hdl.handle.net/20.500.13003/14345

DOI: 10.1186/bcr1233

ISSN: 1465-5411

WOS ID: 000232328800030

Metrics

Export

External links

Publication date

2005

Document type

contribution to journal

Citation

Colomer R, Monzo M, Tusquets I, Rifa J, Baena JM, Barnadas A, et al. Letrozole efficacy is related to human aromatase CYP19 single nucleotide polymorphisms (SNPs) in metastatic breast cancer [meeting abstract]. Breast Cancer Res. 2005;7:S18.

Publisher version

https://dx.doi.org/10.1186/bcr1233

This item appears in following Docusalut collections

Hospital Universitario Son Espases - HUSE > Comunicación científica

This item's license is described as Attribution 4.0 International